author_facet Sterbis, Joseph R.
Gao, Chunling
Furusato, Bungo
Chen, Yongmei
Shaheduzzaman, Syed
Ravindranath, Lakshmi
Osborn, David J.
Rosner, Inger L.
Dobi, Albert
McLeod, David G.
Sesterhenn, Isabell A.
Srivastava, Shiv
Cullen, Jennifer
Petrovics, Gyorgy
Sterbis, Joseph R.
Gao, Chunling
Furusato, Bungo
Chen, Yongmei
Shaheduzzaman, Syed
Ravindranath, Lakshmi
Osborn, David J.
Rosner, Inger L.
Dobi, Albert
McLeod, David G.
Sesterhenn, Isabell A.
Srivastava, Shiv
Cullen, Jennifer
Petrovics, Gyorgy
author Sterbis, Joseph R.
Gao, Chunling
Furusato, Bungo
Chen, Yongmei
Shaheduzzaman, Syed
Ravindranath, Lakshmi
Osborn, David J.
Rosner, Inger L.
Dobi, Albert
McLeod, David G.
Sesterhenn, Isabell A.
Srivastava, Shiv
Cullen, Jennifer
Petrovics, Gyorgy
spellingShingle Sterbis, Joseph R.
Gao, Chunling
Furusato, Bungo
Chen, Yongmei
Shaheduzzaman, Syed
Ravindranath, Lakshmi
Osborn, David J.
Rosner, Inger L.
Dobi, Albert
McLeod, David G.
Sesterhenn, Isabell A.
Srivastava, Shiv
Cullen, Jennifer
Petrovics, Gyorgy
Clinical Cancer Research
Higher Expression of the Androgen-Regulated Gene PSA/HK3 mRNA in Prostate Cancer Tissues Predicts Biochemical Recurrence-Free Survival
Cancer Research
Oncology
author_sort sterbis, joseph r.
spelling Sterbis, Joseph R. Gao, Chunling Furusato, Bungo Chen, Yongmei Shaheduzzaman, Syed Ravindranath, Lakshmi Osborn, David J. Rosner, Inger L. Dobi, Albert McLeod, David G. Sesterhenn, Isabell A. Srivastava, Shiv Cullen, Jennifer Petrovics, Gyorgy 1078-0432 1557-3265 American Association for Cancer Research (AACR) Cancer Research Oncology http://dx.doi.org/10.1158/1078-0432.ccr-07-1356 <jats:title>Abstract</jats:title> <jats:p>Purpose: Alterations of the androgen receptor (AR)-mediated signaling through numerous mechanisms are increasingly recognized in prostate cancer (CaP) progression. We hypothesized that the assessment of well-defined AR transcriptional targets (e.g., PSA/HK3 mRNA) in CaP tissues will provide in vivo readout of AR dysfunctions. Moreover, quantitative expression features of PSA/HK3 mRNA in prostate tumor cells may serve as a prognostic indicator of disease progression.</jats:p> <jats:p>Experimental Design: Paired benign and malignant epithelial cells (242 specimens) were obtained from laser capture microdissection of frozen OCT-embedded tissue sections prepared from radical prostatectomy specimens of 121 patients. Quantitative expression of PSA/HK3 mRNA in the matched malignant and benign cells was analyzed by real-time reverse transcription-PCR.</jats:p> <jats:p>Results: CaP cells express significantly lower PSA/HK3 mRNA levels than matched benign cells (P = 0.0133). Moreover, low PSA/HK3 mRNA expression in malignant cells was associated with increased risk of biochemical recurrence (P = 0.0217), as well as with time to recurrence (P = 0.0371), in patients with intermediate preoperative serum prostate-specific antigen levels (2-10 ng/mL). The expression of androgen-dependent genes in clinical samples correlates with each other in patients with higher expression of PSA/HK3 mRNA but not in patients with lower expression of PSA/HK3 mRNA reflecting AR pathway dysfunction.</jats:p> <jats:p>Conclusions: Our study has unraveled a novel prognostic utility of quantitative measurements of PSA/HK3 mRNA reflecting AR transcriptional activity in CaP cells, which is independent of serum prostate-specific antigen. It also has potential in stratifying subsets of patients exhibiting progressive disease associated with dampened AR transcriptional functions who may be targeted by tailored therapeutic strategies.</jats:p> Higher Expression of the Androgen-Regulated Gene <i>PSA/HK3</i> mRNA in Prostate Cancer Tissues Predicts Biochemical Recurrence-Free Survival Clinical Cancer Research
doi_str_mv 10.1158/1078-0432.ccr-07-1356
facet_avail Online
Free
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1OC8xMDc4LTA0MzIuY2NyLTA3LTEzNTY
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1OC8xMDc4LTA0MzIuY2NyLTA3LTEzNTY
institution DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
imprint American Association for Cancer Research (AACR), 2008
imprint_str_mv American Association for Cancer Research (AACR), 2008
issn 1557-3265
1078-0432
issn_str_mv 1557-3265
1078-0432
language English
mega_collection American Association for Cancer Research (AACR) (CrossRef)
match_str sterbis2008higherexpressionoftheandrogenregulatedgenepsahk3mrnainprostatecancertissuespredictsbiochemicalrecurrencefreesurvival
publishDateSort 2008
publisher American Association for Cancer Research (AACR)
recordtype ai
record_format ai
series Clinical Cancer Research
source_id 49
title Higher Expression of the Androgen-Regulated Gene PSA/HK3 mRNA in Prostate Cancer Tissues Predicts Biochemical Recurrence-Free Survival
title_unstemmed Higher Expression of the Androgen-Regulated Gene PSA/HK3 mRNA in Prostate Cancer Tissues Predicts Biochemical Recurrence-Free Survival
title_full Higher Expression of the Androgen-Regulated Gene PSA/HK3 mRNA in Prostate Cancer Tissues Predicts Biochemical Recurrence-Free Survival
title_fullStr Higher Expression of the Androgen-Regulated Gene PSA/HK3 mRNA in Prostate Cancer Tissues Predicts Biochemical Recurrence-Free Survival
title_full_unstemmed Higher Expression of the Androgen-Regulated Gene PSA/HK3 mRNA in Prostate Cancer Tissues Predicts Biochemical Recurrence-Free Survival
title_short Higher Expression of the Androgen-Regulated Gene PSA/HK3 mRNA in Prostate Cancer Tissues Predicts Biochemical Recurrence-Free Survival
title_sort higher expression of the androgen-regulated gene <i>psa/hk3</i> mrna in prostate cancer tissues predicts biochemical recurrence-free survival
topic Cancer Research
Oncology
url http://dx.doi.org/10.1158/1078-0432.ccr-07-1356
publishDate 2008
physical 758-763
description <jats:title>Abstract</jats:title> <jats:p>Purpose: Alterations of the androgen receptor (AR)-mediated signaling through numerous mechanisms are increasingly recognized in prostate cancer (CaP) progression. We hypothesized that the assessment of well-defined AR transcriptional targets (e.g., PSA/HK3 mRNA) in CaP tissues will provide in vivo readout of AR dysfunctions. Moreover, quantitative expression features of PSA/HK3 mRNA in prostate tumor cells may serve as a prognostic indicator of disease progression.</jats:p> <jats:p>Experimental Design: Paired benign and malignant epithelial cells (242 specimens) were obtained from laser capture microdissection of frozen OCT-embedded tissue sections prepared from radical prostatectomy specimens of 121 patients. Quantitative expression of PSA/HK3 mRNA in the matched malignant and benign cells was analyzed by real-time reverse transcription-PCR.</jats:p> <jats:p>Results: CaP cells express significantly lower PSA/HK3 mRNA levels than matched benign cells (P = 0.0133). Moreover, low PSA/HK3 mRNA expression in malignant cells was associated with increased risk of biochemical recurrence (P = 0.0217), as well as with time to recurrence (P = 0.0371), in patients with intermediate preoperative serum prostate-specific antigen levels (2-10 ng/mL). The expression of androgen-dependent genes in clinical samples correlates with each other in patients with higher expression of PSA/HK3 mRNA but not in patients with lower expression of PSA/HK3 mRNA reflecting AR pathway dysfunction.</jats:p> <jats:p>Conclusions: Our study has unraveled a novel prognostic utility of quantitative measurements of PSA/HK3 mRNA reflecting AR transcriptional activity in CaP cells, which is independent of serum prostate-specific antigen. It also has potential in stratifying subsets of patients exhibiting progressive disease associated with dampened AR transcriptional functions who may be targeted by tailored therapeutic strategies.</jats:p>
container_issue 3
container_start_page 758
container_title Clinical Cancer Research
container_volume 14
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792347904789184521
geogr_code not assigned
last_indexed 2024-03-01T18:02:42.375Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Higher+Expression+of+the+Androgen-Regulated+Gene+PSA%2FHK3+mRNA+in+Prostate+Cancer+Tissues+Predicts+Biochemical+Recurrence-Free+Survival&rft.date=2008-02-01&genre=article&issn=1557-3265&volume=14&issue=3&spage=758&epage=763&pages=758-763&jtitle=Clinical+Cancer+Research&atitle=Higher+Expression+of+the+Androgen-Regulated+Gene+%3Ci%3EPSA%2FHK3%3C%2Fi%3E+mRNA+in+Prostate+Cancer+Tissues+Predicts+Biochemical+Recurrence-Free+Survival&aulast=Petrovics&aufirst=Gyorgy&rft_id=info%3Adoi%2F10.1158%2F1078-0432.ccr-07-1356&rft.language%5B0%5D=eng
SOLR
_version_ 1792347904789184521
author Sterbis, Joseph R., Gao, Chunling, Furusato, Bungo, Chen, Yongmei, Shaheduzzaman, Syed, Ravindranath, Lakshmi, Osborn, David J., Rosner, Inger L., Dobi, Albert, McLeod, David G., Sesterhenn, Isabell A., Srivastava, Shiv, Cullen, Jennifer, Petrovics, Gyorgy
author_facet Sterbis, Joseph R., Gao, Chunling, Furusato, Bungo, Chen, Yongmei, Shaheduzzaman, Syed, Ravindranath, Lakshmi, Osborn, David J., Rosner, Inger L., Dobi, Albert, McLeod, David G., Sesterhenn, Isabell A., Srivastava, Shiv, Cullen, Jennifer, Petrovics, Gyorgy, Sterbis, Joseph R., Gao, Chunling, Furusato, Bungo, Chen, Yongmei, Shaheduzzaman, Syed, Ravindranath, Lakshmi, Osborn, David J., Rosner, Inger L., Dobi, Albert, McLeod, David G., Sesterhenn, Isabell A., Srivastava, Shiv, Cullen, Jennifer, Petrovics, Gyorgy
author_sort sterbis, joseph r.
container_issue 3
container_start_page 758
container_title Clinical Cancer Research
container_volume 14
description <jats:title>Abstract</jats:title> <jats:p>Purpose: Alterations of the androgen receptor (AR)-mediated signaling through numerous mechanisms are increasingly recognized in prostate cancer (CaP) progression. We hypothesized that the assessment of well-defined AR transcriptional targets (e.g., PSA/HK3 mRNA) in CaP tissues will provide in vivo readout of AR dysfunctions. Moreover, quantitative expression features of PSA/HK3 mRNA in prostate tumor cells may serve as a prognostic indicator of disease progression.</jats:p> <jats:p>Experimental Design: Paired benign and malignant epithelial cells (242 specimens) were obtained from laser capture microdissection of frozen OCT-embedded tissue sections prepared from radical prostatectomy specimens of 121 patients. Quantitative expression of PSA/HK3 mRNA in the matched malignant and benign cells was analyzed by real-time reverse transcription-PCR.</jats:p> <jats:p>Results: CaP cells express significantly lower PSA/HK3 mRNA levels than matched benign cells (P = 0.0133). Moreover, low PSA/HK3 mRNA expression in malignant cells was associated with increased risk of biochemical recurrence (P = 0.0217), as well as with time to recurrence (P = 0.0371), in patients with intermediate preoperative serum prostate-specific antigen levels (2-10 ng/mL). The expression of androgen-dependent genes in clinical samples correlates with each other in patients with higher expression of PSA/HK3 mRNA but not in patients with lower expression of PSA/HK3 mRNA reflecting AR pathway dysfunction.</jats:p> <jats:p>Conclusions: Our study has unraveled a novel prognostic utility of quantitative measurements of PSA/HK3 mRNA reflecting AR transcriptional activity in CaP cells, which is independent of serum prostate-specific antigen. It also has potential in stratifying subsets of patients exhibiting progressive disease associated with dampened AR transcriptional functions who may be targeted by tailored therapeutic strategies.</jats:p>
doi_str_mv 10.1158/1078-0432.ccr-07-1356
facet_avail Online, Free
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1OC8xMDc4LTA0MzIuY2NyLTA3LTEzNTY
imprint American Association for Cancer Research (AACR), 2008
imprint_str_mv American Association for Cancer Research (AACR), 2008
institution DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1
issn 1557-3265, 1078-0432
issn_str_mv 1557-3265, 1078-0432
language English
last_indexed 2024-03-01T18:02:42.375Z
match_str sterbis2008higherexpressionoftheandrogenregulatedgenepsahk3mrnainprostatecancertissuespredictsbiochemicalrecurrencefreesurvival
mega_collection American Association for Cancer Research (AACR) (CrossRef)
physical 758-763
publishDate 2008
publishDateSort 2008
publisher American Association for Cancer Research (AACR)
record_format ai
recordtype ai
series Clinical Cancer Research
source_id 49
spelling Sterbis, Joseph R. Gao, Chunling Furusato, Bungo Chen, Yongmei Shaheduzzaman, Syed Ravindranath, Lakshmi Osborn, David J. Rosner, Inger L. Dobi, Albert McLeod, David G. Sesterhenn, Isabell A. Srivastava, Shiv Cullen, Jennifer Petrovics, Gyorgy 1078-0432 1557-3265 American Association for Cancer Research (AACR) Cancer Research Oncology http://dx.doi.org/10.1158/1078-0432.ccr-07-1356 <jats:title>Abstract</jats:title> <jats:p>Purpose: Alterations of the androgen receptor (AR)-mediated signaling through numerous mechanisms are increasingly recognized in prostate cancer (CaP) progression. We hypothesized that the assessment of well-defined AR transcriptional targets (e.g., PSA/HK3 mRNA) in CaP tissues will provide in vivo readout of AR dysfunctions. Moreover, quantitative expression features of PSA/HK3 mRNA in prostate tumor cells may serve as a prognostic indicator of disease progression.</jats:p> <jats:p>Experimental Design: Paired benign and malignant epithelial cells (242 specimens) were obtained from laser capture microdissection of frozen OCT-embedded tissue sections prepared from radical prostatectomy specimens of 121 patients. Quantitative expression of PSA/HK3 mRNA in the matched malignant and benign cells was analyzed by real-time reverse transcription-PCR.</jats:p> <jats:p>Results: CaP cells express significantly lower PSA/HK3 mRNA levels than matched benign cells (P = 0.0133). Moreover, low PSA/HK3 mRNA expression in malignant cells was associated with increased risk of biochemical recurrence (P = 0.0217), as well as with time to recurrence (P = 0.0371), in patients with intermediate preoperative serum prostate-specific antigen levels (2-10 ng/mL). The expression of androgen-dependent genes in clinical samples correlates with each other in patients with higher expression of PSA/HK3 mRNA but not in patients with lower expression of PSA/HK3 mRNA reflecting AR pathway dysfunction.</jats:p> <jats:p>Conclusions: Our study has unraveled a novel prognostic utility of quantitative measurements of PSA/HK3 mRNA reflecting AR transcriptional activity in CaP cells, which is independent of serum prostate-specific antigen. It also has potential in stratifying subsets of patients exhibiting progressive disease associated with dampened AR transcriptional functions who may be targeted by tailored therapeutic strategies.</jats:p> Higher Expression of the Androgen-Regulated Gene <i>PSA/HK3</i> mRNA in Prostate Cancer Tissues Predicts Biochemical Recurrence-Free Survival Clinical Cancer Research
spellingShingle Sterbis, Joseph R., Gao, Chunling, Furusato, Bungo, Chen, Yongmei, Shaheduzzaman, Syed, Ravindranath, Lakshmi, Osborn, David J., Rosner, Inger L., Dobi, Albert, McLeod, David G., Sesterhenn, Isabell A., Srivastava, Shiv, Cullen, Jennifer, Petrovics, Gyorgy, Clinical Cancer Research, Higher Expression of the Androgen-Regulated Gene PSA/HK3 mRNA in Prostate Cancer Tissues Predicts Biochemical Recurrence-Free Survival, Cancer Research, Oncology
title Higher Expression of the Androgen-Regulated Gene PSA/HK3 mRNA in Prostate Cancer Tissues Predicts Biochemical Recurrence-Free Survival
title_full Higher Expression of the Androgen-Regulated Gene PSA/HK3 mRNA in Prostate Cancer Tissues Predicts Biochemical Recurrence-Free Survival
title_fullStr Higher Expression of the Androgen-Regulated Gene PSA/HK3 mRNA in Prostate Cancer Tissues Predicts Biochemical Recurrence-Free Survival
title_full_unstemmed Higher Expression of the Androgen-Regulated Gene PSA/HK3 mRNA in Prostate Cancer Tissues Predicts Biochemical Recurrence-Free Survival
title_short Higher Expression of the Androgen-Regulated Gene PSA/HK3 mRNA in Prostate Cancer Tissues Predicts Biochemical Recurrence-Free Survival
title_sort higher expression of the androgen-regulated gene <i>psa/hk3</i> mrna in prostate cancer tissues predicts biochemical recurrence-free survival
title_unstemmed Higher Expression of the Androgen-Regulated Gene PSA/HK3 mRNA in Prostate Cancer Tissues Predicts Biochemical Recurrence-Free Survival
topic Cancer Research, Oncology
url http://dx.doi.org/10.1158/1078-0432.ccr-07-1356